Alka Palekar

2.5k total citations
31 papers, 1.8k citations indexed

About

Alka Palekar is a scholar working on Pathology and Forensic Medicine, Oncology and Cancer Research. According to data from OpenAlex, Alka Palekar has authored 31 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Pathology and Forensic Medicine, 10 papers in Oncology and 8 papers in Cancer Research. Recurrent topics in Alka Palekar's work include Breast Lesions and Carcinomas (13 papers), Breast Cancer Treatment Studies (8 papers) and Cancer and Skin Lesions (4 papers). Alka Palekar is often cited by papers focused on Breast Lesions and Carcinomas (13 papers), Breast Cancer Treatment Studies (8 papers) and Cancer and Skin Lesions (4 papers). Alka Palekar collaborates with scholars based in United States, Italy and Belgium. Alka Palekar's co-authors include Edwin R. Fisher, Bernard Fisher, Carol Redmond, Steven H. Itzkowitz, Young S. Kim, Joseph P. Costantino, Benjamin F. Trump, Mei Yuan, Patricia C. Phelps and Abulkalam M. Shamsuddin and has published in prestigious journals such as SHILAP Revista de lepidopterología, JNCI Journal of the National Cancer Institute and Cancer.

In The Last Decade

Alka Palekar

31 papers receiving 1.7k citations

Peers

Alka Palekar
Joost J. Oudejans Netherlands
Maryou B. Lambros United Kingdom
Natália Buza United States
Stephen E. Karp United States
Sherri Z. Millis United States
E. Lin United States
L Andrac France
Alka Palekar
Citations per year, relative to Alka Palekar Alka Palekar (= 1×) peers Takashi Hojo

Countries citing papers authored by Alka Palekar

Since Specialization
Citations

This map shows the geographic impact of Alka Palekar's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alka Palekar with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alka Palekar more than expected).

Fields of papers citing papers by Alka Palekar

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Alka Palekar. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alka Palekar. The network helps show where Alka Palekar may publish in the future.

Co-authorship network of co-authors of Alka Palekar

This figure shows the co-authorship network connecting the top 25 collaborators of Alka Palekar. A scholar is included among the top collaborators of Alka Palekar based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Alka Palekar. Alka Palekar is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Schoedel, Karen, et al.. (2016). Ossifying fibromyxoid tumor: a study of 6 cases of atypical and malignant variants. Human Pathology. 60. 174–179. 13 indexed citations
2.
Schoedel, Karen, et al.. (2016). CDK8 Expression in Extrauterine Leiomyosarcoma Correlates With Tumor Stage and Progression. Applied immunohistochemistry & molecular morphology. 26(3). 161–164. 2 indexed citations
3.
Palekar, Alka, et al.. (2015). Human Immunodeficiency Virus-associated primary effusion lymphoma: An exceedingly rare entity in cerebrospinal fluid. CytoJournal. 12. 22–22. 5 indexed citations
4.
Pradhan, Dinesh, Sara E. Monaco, Alka Palekar, Juan Xing, & Liron Pantanowitz. (2015). Cytological Evaluation of Malignant Joint Fluid Specimens: Rare but Important Finding. Journal of the American Society of Cytopathology. 4(6). S85–S85. 1 indexed citations
5.
Monaco, Sara E., et al.. (2014). Cytomorphology of metastatic balloon cell melanoma. Diagnostic Cytopathology. 43(6). 485–487. 4 indexed citations
6.
Papachristou, Dionysios J., Alka Palekar, Urvashi Surti, et al.. (2009). Malignant granular cell tumor of the ulnar nerve with novel cytogenetic and molecular genetic findings. Cancer Genetics and Cytogenetics. 191(1). 46–50. 19 indexed citations
7.
Fisher, Edwin R., Joseph P. Costantino, Marino E. Leon, et al.. (2007). Pathobiology of small invasive breast cancers without metastases (T1a/b, N0, M0). Cancer. 110(9). 1929–1936. 22 indexed citations
8.
Fisher, Edwin R., Joseph P. Costantino, Bernard Fisher, et al.. (1996). Pathologic findings from the National Surgical Adjuvant Breast Project (NSABP) protocol B-17: Five-year observations concerning lobular carcinoma in situ. Cancer. 78(7). 1403–1416. 99 indexed citations
9.
Fisher, Edwin R., Joseph P. Costantino, Bernard Fisher, Alka Palekar, & Carol Redmond. (1995). Pathologic findings from the national surgical adjuvant breast project (NSABP) protocol B-17. Intraductal carcinoma (ductal carcinoma in situ). Cancer. 75(6). 1310–1319. 243 indexed citations
10.
Fisher, Edwin R., et al.. (1994). Mucocele-like Lesions and Mucinous Carcinoma of the Breast. International Journal of Surgical Pathology. 1(4). 213–220. 2 indexed citations
11.
Fisher, Edwin R., et al.. (1989). Dukes' classification revisited. Findings from the national surgical adjuvant breast and bowel projects (protocol r‐01). Cancer. 64(11). 2354–2360. 69 indexed citations
12.
Yuan, Min, Steven H. Itzkowitz, Linda D. Ferrell, et al.. (1987). Expression of Lewis<sup>X</sup> and Sialylated Lewis<sup>X</sup> Antigens in Human Colorectal Polyps<xref ref-type="fn" rid="FN2">2</xref>. JNCI Journal of the National Cancer Institute. 78(3). 479–88. 46 indexed citations
13.
Yuan, Mei, et al.. (1986). Comparison of T-antigen expression in normal, premalignant, and malignant human colonic tissue using lectin and antibody immunohistochemistry.. PubMed. 46(9). 4841–7. 97 indexed citations
14.
Kim, Young S., Mei Yuan, Steven H. Itzkowitz, et al.. (1986). Expression of LeY and extended LeY blood group-related antigens in human malignant, premalignant, and nonmalignant colonic tissues.. PubMed. 46(11). 5985–92. 157 indexed citations
15.
Fisher, Edwin R., Alka Palekar, Richard Sass, & Bernard Fisher. (1983). Scar cancers: Pathologic findings from the National Surgical Adjuvant Breast Project (Protocol No. 4) — IX. Breast Cancer Research and Treatment. 3(1). 39–59. 33 indexed citations
16.
Fisher, Edwin R., Alka Palekar, Carol Redmond, Bruce Barton, & Bernard Fisher. (1980). Pathologic Findings from the National Surgical Adjuvant Breast Project (Protocol No. 4): VI. Invasive Papillary Cancer. American Journal of Clinical Pathology. 73(3). 313–322. 123 indexed citations
17.
Fisher, Edwin R., Alka Palekar, John D. Paulson, & Ronald C. Golinger. (1979). Pseudolymphoma of breast. Cancer. 44(1). 258–263. 23 indexed citations
18.
Fisher, Edwin R., et al.. (1979). A Nonencapsulated Sclerosing Lesion of the Breast. American Journal of Clinical Pathology. 71(3). 240–246. 67 indexed citations
19.
Fisher, Edwin R., Alka Palekar, Remigio M. Gregorio, Carol Redmond, & Bernard Fisher. (1978). Pathological findings from the national surgical adjuvant breast project (protocol no. 4). IV. Significance of tumor necrosis. Human Pathology. 9(5). 523–530. 49 indexed citations
20.
Fisher, Edwin R., et al.. (1978). Comparative Histopathologic, Histochemical, Electron Microscopic and Tissue Culture Studies of Bronchial Carcinoids and Oat Cell Carcinomas of Lung. American Journal of Clinical Pathology. 69(2). 165–172. 62 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026